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Abstract
Background: Photo-activation of the hydrophobic membrane probe 1, 5 iodonaphthylazide (INA)
by irradiation with UV light (310–380 nm) results in the covalent modification of transmembrane
anchors of membrane proteins. This unique selectivity of INA towards the transmembrane anchor
has been exploited to specifically label proteins inserted in membranes. Previously, we have
demonstrated that photo-activation of INA in enveloped viruses resulted in the inhibition of viral
membrane protein-induced membrane fusion and viral entry into cells. In this study we show that
photo-activation of INA in various cell lines, including those over-expressing the multi-drug
resistance transporters MRP1 or Pgp, leads to cell death. We analyzed mechanisms of cell killing
by INA-UV treatment. The effects of INA-UV treatment on signaling via various cell surface
receptors, on the activity of the multi-drug resistance transporter MRP1 and on membrane protein
lateral mobility were also investigated.
Results: INA treatment of various cell lines followed by irradiation with UV light (310–380 nm)
resulted in loss of cell viability in a dose dependent manner. The mechanism of cell death appeared
to be apoptosis as indicated by phosphatidylserine exposure, mitochondrial depolarization and
DNA fragmentation. Inhibition by pan-caspase inhibitors and cleavage of caspase specific substrates
indicated that at low concentrations of INA apoptosis was caspase dependent. The INA-UV
treatment showed similar cell killing efficacy in cells over-expressing MRP1 function as control cells.
Efflux of an MRP1 substrate was blocked by INA-UV treatment of the MRP1-overexpressing cells.
Although INA-UV treatment resulted in inhibition of calcium mobilization triggered by chemokine
receptor signaling, Akt phosphorylation triggered by IGF1 receptor signaling was enhanced.
Furthermore, fluorescence recovery after photobleaching experiments indicated that INA-UV
treatment resulted in reduced lateral mobility of a seven transmembrane G protein-coupled
receptor.
Conclusion: INA is a photo-activable agent that induces apoptosis in various cancer cell lines. It
reacts with membrane proteins to alter the normal physiological function resulting in apoptosis.
This activity of INA maybe exploited for use as an anti-cancer agent.
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Background
Cells have developed a complex architecture that relies on
the compartmentalization of cellular functions within
organelles that are bounded by lipid membranes. The
plasma membrane constitutes a unique interface between
the cytoplasm and extra cellular milieu. While ensuring
the physical separation of two very different environ-
ments, a constant communication between the cell and its
extracellular milieu is established by means of cell surface
proteins. Signaling via membrane proteins regulate vari-
ous cellular functions including cell survival, cell propaga-
tion, cell differentiation and cell migration. Therefore
membrane proteins are considered prime targets for drugs
designed to combat cancer and other diseases. While inhi-
bition of a given cell surface receptor often leads to pre-
dictable changes in cells based on the signaling cascade
initiated by the receptor, it is unclear how altering cell sig-
naling via a number of receptors would change the cell
physiology.
INA is a hydrophobic photo-reactive probe that reacts
with transmembrane anchors of membrane proteins
upon photo-activation with UV light [1]. INA has been
used for the labeling and identification of integral mem-
brane proteins [2-7], in the study of membrane dynamics
and fusion [8-10] and for the detection of protein-mem-
brane interactions [10-13]. Recently, we have utilized the
transmembrane protein anchor reactivity of INA for inac-
tivation of enveloped viruses [14-17] with preservation of
structural integrity for vaccine application. When applied
to a variety of enveloped viruses, INA could selectively
eliminate functions associated with the hydrophobic
domain of the viral envelope required for inducing mem-
brane fusion [16,17]. Based on this premise we hypothe-
sized that treatment of cancer cells with INA-UV would
result in inactivation of signaling functions of cellular
membrane proteins which in turn would inhibit cell sign-
aling and survival.
With this in mind we conducted the present study to show
that INA, a non toxic compound in itself, is highly toxic to
a variety of tumor cells including multidrug resistant cells
in the presence of UV light. Treatment of cells with INA-
UV resulted in inhibition of signal transduction by certain
cellular receptors and cell death. The cell death induced by
INA-UV showed signs of a classical apoptosis pathway
with the involvement of caspases. This study provides evi-
dence that INA can act as a novel and highly active thera-
peutic agent with a mechanism of action that seems
distinct from existing photodynamic therapy compounds.
Results
Photo-activation of INA inhibits cell viability
INA is a hydrophobic compound that partitions in the
membrane of cells. Upon irradiation of cells with UV light
(310–380 nm) the azido moiety is converted into a highly
reactive nitrene that covalently binds membrane proteins.
This process leads to the selective inactivation of functions
associated with those proteins in the hydrophobic
domain of the membrane as has been previously shown
for isolated cell membranes [18] and enveloped viruses
[14-17]. In this study, we examined the effect of INA-UV
on the viability and membrane associated functions of
different tumor cell lines. We treated a human breast can-
cer cell line MCF7 with varying concentrations of INA and
irradiated with UV light. As seen in figure 1A, treatment of
cells with INA-UV caused significant inhibition of cell via-
bility determined by MTS assay. In the absence of light
INA was non toxic to the cells. The effect of INA-UV was
dose dependent with IC50 of 20.6 μM for MCF7 cells (fig-
ure 1B, table 1). The ability of INA-UV treatment to cause
cell death was not limited to MCF7 cells. Similar results
were obtained with a variety of other cancer cell lines rep-
resenting cervical cancer, glioma, breast carcinoma, ovar-
ian carcinoma, epidermoid carcinoma and
lymphoblastoma (Table 1).
Photo-activation of INA induces apoptosis
Next we asked whether the loss of viability seen by INA-
UV treatment was due to apoptosis induced in these cells.
Apoptosis is characterized by a variety of distinct cellular
changes like phosphatidylserine exposure, mitochondrial
depolarization and DNA fragmentation. MCF7 cells
treated with various concentrations of INA-UV were ana-
lyzed for apoptosis markers like mitochondrial depolari-
zation using DiOC6 dye (figure 2A) or phosphatidylserine
exposure via Annexin V staining (figure 2B). A dose
dependent induction of apoptosis was seen in these cells.
To further characterize whether the cells were undergoing
apoptosis we used the TUNEL assay to detect DNA frag-
mentation. As seen in figure 2C the cells treated with INA-
UV also showed DNA fragmentation confirming the
apoptotic mechanism of cell death.
Apoptosis mediated by INA-UV is caspase dependent
Caspases are cysteine proteases that are key mediators of
apoptosis [19]. The involvement of caspases in the apop-
totic pathway can be studied by the inhibition of apopto-
sis via the pan-caspase inhibitor Z-Val-Ala-Asp-
fluoromethylketone (ZVADfmk) and the cleavage of cas-
pase specific substrates like PARP [20,21]. To determine
whether apoptosis mediated via INA-UV treatment was
caspase dependent, we treated SupT1 cells with ZVADfmk
(40 μM) prior to INA-UV treatment. As seen in figure 3A
and 3B INA-UV mediated apoptosis at low concentrations
was inhibited by ZVADfmk confirming the role of cas-
pases. Interestingly higher concentrations were not inhib-
ited by ZVADfmk suggesting a different mechanism at
very high concentrations. In order to monitor caspase acti-
vation in SupT1 cells 24 h post treatment with INA-UV,BMC Cell Biology 2009, 10:21 http://www.biomedcentral.com/1471-2121/10/21
Page 3 of 14
(page number not for citation purposes)
the cells were labeled FITC-VAD-FMK which binds irre-
versibly with active caspases and analyzed by flow cytom-
etry. As seen in figure 3C, high activation of caspases is
observed at 5 μM which correspond to the IC50 of INA-UV
treatment of SupT1 cells. The activation of caspases was
lower at higher doses as determined by FITC-VAD-FMK
staining. These findings are supported by the high levels
of PARP cleavage seen at low INA concentrations whereas
there was little PARP cleavage at higher INA concentra-
tions (figure 3D). PARP cleavage was prevented at all INA
concentrations by ZVADfmk indicating its caspase specif-
icity (data not shown). To generalize our conclusion
about mechanisms of cell killing, we performed similar
experiments with Hela cells. As shown in figure 4, the
major caspase involvement in Hela cells takes place at 10
μM INA. At higher INA concentrations ZVADfmk
becomes inefficient in preventing apoptosis (figure 4A)
and PARP cleavage is decreased (figure 4B). The enhanced
caspase activity was observed at 5 μM INA for SupT1 cells
and 10 μM INA for Hela cells, which corresponds in each
case to the IC50 at which INA causes cell death following
photo-activation. These studies therefore suggest that in
the IC50 range of concentrations of INA the apoptosis is
mediated by caspases. However, at higher INA concentra-
INA activated by UV prevents MCF7 propagation Figure 1
INA activated by UV prevents MCF7 propagation. The effect of INA treatment on the propagation of MCF7 cells was 
measured by a MTS assay. A. Cells were treated with 60 μM INA, 1% DMSO or used as is (control). They were then either 
exposed to UV light or kept in the dark (no UV). MTS measurements were performed 24 h later. B. Cells were treated with 
increasing amounts of INA and irradiated with UV. MTS measurements were performed after 24 h. Data are mean ± S.D of 
seven measurements.
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Table 1: Cytotoxic activity of INA-UV treatment measured on different cancer cell lines by the MTS assay
Cell line Human cancer types IC50 ± SE (μM)*
MCF7 Breast adenocarcinoma 20.6 ± 8.8
HeLa Cervical cancer 11.2 ± 1.7
U251 Glioma 15.4 ± 1.0
SKOV-3 Ovarian carcinoma 17.6 ± 1.0
SKBR-3 Breast carcinoma 7.8 ± 1.5
KB3-1 Epidermoid carcinoma 16.0 ± 0.7
KBV1 Epidermoid carcinoma overexpressing Pgp 12.3 ± 4.4
293 Epithelial cell line from embryonic kidney 8.6 ± 0.9
293/MRP1 Epithelial cell line from embryonic kidney overexpressing MRP1 7.3 ± 1.0
SupT1 T lymphoblastoid 4.9 ± 0.6
* Seven independent measurements were performed and analyzed together. IC50 values were computed by fitting a four-parameter nonlinear 
regression model with R statistical software [57]. The standard error (SE) represents the 95% confidence interval.BMC Cell Biology 2009, 10:21 http://www.biomedcentral.com/1471-2121/10/21
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tions a caspase-independent apoptotic process may be
involved.
INA-UV induced cell killing is not affected by multidrug 
resistance proteins
An important problem that arises during chemotherapy is
the emergence of drug resistant cells [22]. A major con-
tributor of that phenomenon is an increased efflux of the
drugs facilitated by proteins such as the P-glycoprotein
(Pgp) or the multidrug resistance protein (MRP) [23-25].
To test whether INA was affected by this phenomenon we
used 293/MRP1 cells, a stably transfected 293 cell line that
continuously expresses the MRP1 gene at high levels [26].
Indeed, those cell lines exhibited a much lower sensitivity
to the commonly used chemotherapeutic agent doxoru-
bicin (figure 5A). However, the IC50 of INA-UV cell killing
was insensitive to the presence of the multidrug resistance
associated gene MRP1 (figure 5B, table 1). Similarly, INA-
UV treatment was not significantly affected by Pgp over-
expression (table 1).
INA-UV treatment blocks the MRP1 induced efflux
MRP1 is a complex transmembrane protein with 17 mem-
brane spanning domains that mediates efflux of various
substrates from the cytoplasm of the cell to the extracellu-
lar milieu. Calcein is an anionic fluorescent probe that
INA-UV treatment induces apoptosis Figure 2
INA-UV treatment induces apoptosis. INA-UV treatment of MCF7 cells induces mitochondrial membrane depolarization 
(DiOC6 staining), phosphatidyl serine exposure (Annexin V binding) and DNA fragmentation (TUNEL assay). MCF7 cells 
treated with increasing amounts of INA and irradiated with UV were stained with DiOC6 (A) or Annexin V (B). The percent-
age of the population with low DiOC6 staining (depolarized mitochondria) or high Annexin V staining (PS exposure on the cell 
surface) were determined by FACS analysis and plotted as a function of the INA used for the treatment. Data are mean ± S.D. 
Representative graphs from two independent experiments are presented. C. Histograms corresponding to the TUNEL staining 
of MCF7 cells treated with different amounts of INA and irradiated with UV.
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acts as a substrate for MRP1 and determination of its cel-
lular accumulation and efflux allows the investigation of
MRP1 activity [27]. As observed in figure 6A, after one
hour incubation at 37°C, the 293 cells expressing MRP1
have released a significant portion of the entrapped cal-
cein as evident from the lower fluorescence seen by flow
cytometry. This efflux was prevented by incubation of the
cells with verapamil (40 μM), an inhibitor of MRP1 func-
tion, yielding a labeling efficiency with calcein similar to
the one obtained with 293 that do not express MRP1 (fig-
ure 6A). Interestingly pre-treatment of the 293/MRP1 cells
with INA-UV induced a similar block in MRP1 function as
observed with verapamil (figure 6A). On the other hand,
in control cells lacking MRP1 neither verapamil nor INA-
UV treatment had any significant effect on calcein efflux
(figure 6B). This suggests that the increase in calcein labe-
ling in INA-UV treated MRP1 positive cells was in fact due
to a specific inhibition of MRP1 function. This is consist-
ent with the inactivation of transmembrane proteins by
INA labeling.
INA-UV affects CXCR4 signaling
CXCR4 is a seven transmembrane G protein-coupled
chemokine receptor that is over-expressed in a variety of
INA-UV induced apoptosis in SupT1 cells is mediated by caspases Figure 3
INA-UV induced apoptosis in SupT1 cells is mediated by caspases. A, B. SupT1 cells, pre-incubated or not with 40 
μM ZVADfmk were treated with indicated amounts of INA, irradiated with UV and analyzed 24 h post treatment. A. Cells 
were stained with DiOC6 and analyzed by FACS. The percentage of the population presenting low staining (depolarized mito-
chondria) is presented. B. Cells were stained with Annexin V and analyzed by FACS. The percentage of the population pre-
senting high staining (PS exposure) is presented. C. Cells were stained with FITC-VAD-FMK and analyzed by FACS. The 
percentage of the population presenting high staining (caspase activated) is presented. Data are mean ± S.D. Respresentative 
graphs of two independent experiments are presented. D. SupT1 cells were treated with indicated amounts of INA or doxoru-
bicin. 24 hours upon treatment, the cells were lysed and the presence of PARP and/or cleaved PARP was assessed by Western 
analysis. Loading equivalence was assessed by Western blot analysis of GAPDH.
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tumors and involved in tumor metastasis [28]. In cell
membranes, blocking the signaling by INA-UV treatment
of another G protein-coupled receptor, human chorionic
gonadotropin (hCG) has been previously documented
[18]. We wished to determine whether INA-UV treatment
would alter signaling via CXCR4. Binding of the CXCR4
ligand SDF-1α to its receptor induces a calcium flux in
cells, which is monitored by ratio of fluorescent signals at
340 and 380 nm excitation, respectively, and 510 nm
emission using the fluorescent calcium indicator dye, Fura
2 pre-loaded into the cells [29,30]. Upon addition of
SDF1α we observed calcium flux in the control SupT1
cells but not in cells pretreated with INA-UV (figure 7)
suggesting an inhibition of CXCR4 signaling. By contrast,
INA-UV treatment had no effect on the action of the cal-
cium ionophore 4-bromo A-23187 that directly mediates
calcium flux across membranes. When added to SupT1, in
both cases the cytosolic concentration of calcium rose to a
similar level as was shown by the increase of the fura 2
ratio signal (Figure 7). Hence the effect of INA-UV was at
the level of CXCR4 signaling and not a general effect on
intracellular calcium accumulation.
INA-UV does not inhibit IGF1 signaling
Growth factor receptors including EGFR and IGF1R are
often overexpressed in tumor cells. Overexpression of
IGF1R is associated with increased survival and prolifera-
tion of tumor cells. Hence we wished to determine
whether INA-UV had an effect on IGF1R signaling and
whether it was related to the apoptosis seen in previous
experiments. The binding of IGF1 to its receptor activates
the PI3kinase pathway leading to Akt phosphorylation at
serine 473 [31], which has been reported to be involved
in apoptosis inhibition. As can be seen on figure 8, the
pretreatment of MCF7 cells with INA-UV leads to an
amplification of Akt phosphorylation induced by IGF1
compared to untreated cells. While DMSO partially con-
tributed to this effect, further amplification was observed
upon irradiation in the presence of INA. Interestingly we
observe that INA-UV treatment alone, in the absence of
IGF1, can partially induce Akt phosphorylation in MCF7
cells. This effect requires the reaction to transmembrane
proteins with INA, since it is not observed with UV and
DMSO treatment alone. These results suggest that INA-UV
may in fact activate signaling via IGF1R contrary to the
results seen with other receptors. These results underscore
the complex physiological outcome of INA interaction
with cellular receptors and the diversity in the signal trans-
duction mechanism by different receptors.
Treatment affects the mobility of membrane proteins
Our efforts to identify the mechanism of action of INA-UV
mediated apoptosis induction suggest a direct effect on
membrane proteins. Although CXCR4 and MRP1 func-
INA-UV induced apoptosis in Hela cells is also caspase dependent Figure 4
INA-UV induced apoptosis in Hela cells is also caspase dependent. A. Hela cells, pre-incubated or not with 40 μM 
ZVADfmk were treated with indicated amounts of INA, irradiated with UV and analyzed 24 h post treatment. Cells were 
stained with Annexin V and analyzed by FACS. The percentage of the population presenting high staining (PS exposure) is pre-
sented. B. Hela cells were treated with indicated amounts of INA. 24 hours upon treatment, the cells were lysed and the pres-
ence of PARP and/or cleaved PARP was assessed by Western analysis. The ratio of the two as determined by Western analysis 
is represented.
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tions were inhibited by INA-UV treatment, this was not
the case with IGF1R function. Photoactivation of INA
results in the covalent binding of the probe to membrane
proteins in the lipidic bilayer with no particular specifi-
city. This may alter the function of proteins via a variety of
mechanisms including the translational mobility of recep-
tors in the plasma membrane. Hence we sought to assess
the effects of INA modifications on the mobility of mem-
brane proteins using CCR5-GFP as a reporter. FRAP (fluo-
rescence recovery after photobleaching) is a commonly
used method to detect the mobility of fluorescently tagged
protein and lipids in cells. We transiently expressed
CCR5-GFP in Hela cells and performed FRAP measure-
ments with or without INA-UV treatment. As shown in
figure 9 there is a dramatic impact of INA-UV treatment
on fluorescence recovery of CCR5-GFP. Curve-fitting
recovery after photobleaching shows that INA-UV treat-
ment greatly affects the mobile fraction of CCR5-GFP
molecules (figure 9B). INA-UV treatment results in the
immobilization of CCR5-GFP while the effect on the
mobility of lipids is not significant [17]. These results sug-
gest that INA via direct interaction with transmembrane
protein alters the function and mobility of various cellular
receptors.
Discussion
INA is a highly hydrophobic molecule that partitions with
high specificity in cellular membranes [32]. This high
hydrophobicity along with its photoactivable property
makes it a specific probe for transmembrane anchors of
membrane proteins. We have exploited this specificity
towards transmembrane anchors to inactivate a variety of
viral membrane proteins for design of new vaccine candi-
dates [15,17]. In this study we studied the effects of INA-
UV treatment on whole cells. Our results indicate that
treatment of cell lines with INA by itself was non toxic;
however, in the presence of UV light the treatment medi-
ated loss in viability of numerous cancer cells.
The photoactivation of INA is mediated by its azido group
that is sensitive to UV irradiation. Upon UV irradiation, a
highly reactive nitrene radical is formed that covalently
reacts with transmembrane proteins in its vicinity [1].
Such covalent modifications of proteins has been shown
to result in the complete loss of infectivity of several envel-
oped viruses [14-17] and correlates with the loss of mem-
brane fusion function of the viral fusion proteins [16,17].
The transmembrane segments of the fusion proteins of
retroviruses [33] and influenza virus [34] are indeed criti-
cal for the full fusion process to take place. Although
replacement of the transmembrane anchor of influenza
virus hemagglutinin with a lipid-anchor obliterated its
full fusion capacity, the lipid-anchored hemagglutinin
still promoted the hemifusion phenotype leading to the
mixing of the outer layers of the viral and target cell mem-
branes [34]. Consistent with this, INA-UV treatment of
INA-UV treatment is not affected by the expression of multidrug resistant protein Figure 5
INA-UV treatment is not affected by the expression of multidrug resistant protein. The MTS assay was applied to 
assess the viability of MRP1 overexpressing multidrug resistant 293/MRP1 cell (open circles) and its drug sensitive parent cell 
line 293 (close circles) subjected to doxorubicin exposure (A) or to INA-UV treatment (B). A. The cells were exposed to 
doxorubicin at the indicated concentrations for 72 hours and then subjected to the MTS assay. Data are mean ± S.D. B. The 
cells were subjected to INA-UV treatment and then subjected to the MTS assay 24 hours post treatment. Data are mean ± S.D 
of seven measurements.
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influenza preserved the hemifusion phenotype confirm-
ing the requirement of the transmembrane anchor for full
fusion activity and the specific effect of INA on the trans-
membrane anchor without effecting the function of extra-
cellular domains [17].
Treatment of cells with INA and UV irradiation resulted in
complete loss of viability in a variety of cancer cell lines
(table 1). This effect was shown to be dependent on the
concentration of INA used and strictly required activation
by UV light (figure 1). We show here that INA activation
induces cell death via characteristics of apoptosis as deter-
mined by mitochondrial membrane depolarization,
phosphatidyl serine presentation, PARP cleavage and
DNA fragmentation in treated cells. At lower doses of INA,
apoptosis could be reversed by ZVADfmk, a potent pan
caspases inhibitor. Caspase activation was also detected
by FITC-VAD-FMK 24 h post INA-UV treatment showing
the involvement of caspases in this process and confirm-
ing the apoptotic pathway. However, at higher concentra-
tions of INA, caspase activation is decreased and
accordingly ZVADfmk becomes ineffective in preventing
mitochondrial depolarization and PS presentation sug-
gesting a caspase independent pathway of apoptosis as
seen with other treatments like hexaminolevulinate PDT
of lymphoma cells [35]. A caspase independent cell death
referred to as sub apoptosis has been previously docu-
INA-UV treatment inhibits the calcein efflux of MRP1 expressing cells Figure 6
INA-UV treatment inhibits the calcein efflux of MRP1 expressing cells. The loading of calcein by 293/MRP1 and 293 
cells was assessed by FACS analysis. A. Histogram of the calcein fluorescence of 293/MRP1 cells treated or not with 50 μM 
INA-UV or 40 μM verapamil. B. Histogram of the calcein fluorescence of 293 cells treated or not with 50 μM INA-UV or 40 
μM verapamil.
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INA-UV treatment blocks SDF1α induced CXCR4 signaling Figure 7
INA-UV treatment blocks SDF1α induced CXCR4 
signaling. The fluorescence emission of Fura 2 was 
recorded at 510 nm using simultaneous excitation at 340 and 
380 nm. The ratio of the 2 emission signals obtained, 340/
380, is plotted over time. SDF1α was added at time 50 sec as 
indicated and further on the ionophore 4-bromo A-23187 
was added at time ~160 sec as indicated. The same experi-
ment was carried on SupT1 cells (dark curve) or SupT1 cells 
treated with 15 μM INA-UV (grey curve).
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
 
!
"
#
$
%
&
#
’
(
)
*
￿
￿
+
SDF1
SDF1
(
,
-
,
.
/
,
0
1
PBMC Cell Biology 2009, 10:21 http://www.biomedcentral.com/1471-2121/10/21
Page 9 of 14
(page number not for citation purposes)
mented [36]. The death inducing stimulus might be such
that apoptosis can be achieved through release of apopto-
sis inducing factors (AIF) from mitochondria without the
participation of caspases [37].
As the dosage of INA is increased, more targets within the
transmembrane region and possibly other membrane
compartments are likely to be reached by the treatment
and this can alter the mechanisms inducing the death of
the treated cells. If activated INA will covalently react with
any protein that is deeply anchored in the lipid bilayer,
the consequence of this covalent modification will
depend on the function of this portion of the particular
protein. Understanding the effect of INA on cellular pro-
teins is important for determining the mechanism of
apoptosis induction by INA and its development as an
anti cancer agent.
It has been previously reported that INA-UV treatment of
cell membranes induces inactivation of gonadotropin
receptor by uncoupling of the response of adenylate
cyclase to gonadotropins [38]. While binding of chorionic
gonadotropin and the luteinizing hormone to gonadotro-
pin receptor were preserved, the binding failed to induce
stimulation of the adenylate cyclase pathway. On the
other hand, this pathway was shown to be still functional
when stimulated directly with NaF. The luteineizing hor-
mone receptor is a member of the G protein-coupled
receptor, a family of receptors displaying seven predicted
transmembrane helices. CXCR4, another member of this
family, has recently been shown to be overexpressed in
many cancer cell lines [39,40]. This overexpression is
largely due to the hypoxic conditions in the tumor envi-
ronment [41] and can favor the metastasis of cancer cells
through its ligand SDF1α [42-44]. We show here that INA-
UV treatment blocks CXCR4 mediated calcium signaling
generated by SDF1α stimulation. At the same time the cal-
cium gradient is preserved in the INA-UV treated cells as it
is still sensitive to the effect of calcium ionophores indi-
cating that the integrity of the treated cell membranes is
not compromised. These data indicate a direct inactiva-
tion of CXCR4 receptor signaling by INA-UV treatment.
Similarly, the activity of MRP1 a member of the ABC
transporters superfamily that along with Pgp is involved
in the drug resistance phenotype in various cancers [45]
was also affected by INA-UV treatment. Although no crys-
tal structure is yet available for this protein, ABC trans-
porters are thought to be composed of clusters of
predicted transmembrane helices [46]. Overexpression of
drug resistance genes makes cells several orders of magni-
tudes less sensitive to conventional chemotherapeutic
agents. The mechanism of action is not clearly understood
but the working hypothesis of "hydrophobic vacuum
cleaner" has been proposed [7,45] whereby the hydro-
phobic chemotherapeutic agents while partitioning into
the membrane will interact with the transporter within
the lipid domain of the bilayer and be pumped outwards.
The ability of INA to covalently react with members of
ABC transporters has been previously demonstrated [7].
We show here that this interaction leads to the inhibition
of MRP1 function and drug efflux. Our data indicate that
cell killing induced by irradiation at given concentrations
of INA is not affected by the presence of MRP1 or Pgp.
Although INA labeling of MRP1 has previously been dem-
onstrated [7], the lack of difference in IC50 for INA killing
between MRP1+ and MRP1- cells suggests that either INA
is not a substrate for MRP1 or that the Kd for INA binding
to MRP1 is much higher than the IC50 for INA to kill cells
by irradiation. Therefore irradiation in the presence of
INA, and possibly other hydrophobic alkylating agents,
appears to be an effective modality of killing of multi-drug
resistant cells.
Growth receptor signaling via IGF1R and EGFR has been
known to induce cell survival and proliferation in cancer
cells via activation of the PI3Kinase and Akt pathway. The
tyrosine kinase IGF1R mediated Akt phosphorylation was
not affected by INA treatment in cells incubated with
IGF1. Interestingly, increased levels of Akt phosphoryla-
tion were observed in INA treated cells in the absence of
INA-UV treatment does not inhibit IGF1 signaling Figure 8
INA-UV treatment does not inhibit IGF1 signaling. 
Akt phosphorylation was assessed by Western detection and 
quantified. The different samples correspond to MCF7 cells 
untreated, exposed or not to 1% DMSO, INA at the indi-
cated concentrations and/or IGF1. All the samples exposed 
to DMSO or INA were irradiated with UV. The Akt phos-
phorylation signal was normalized to the signal obtained with 
MCF7 exposed only to IGF1. The Western signal obtained 
with GAPDH on the same samples is shown for loading con-
trol.
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IGF1 stimulation, which was further enhanced upon incu-
bation with IGF1. This suggests that INA treatment may
activate IGF1R consistent with reports that a mutation in
the transmembrane anchor of IGF1R can result in activa-
tion of the receptor [47]. The effects of INA can be inter-
preted through intramolecular effects via the chemical
modification introduced by the covalent addition of a
hydrophobic moiety in the transmembrane segment of a
protein. However protein-protein and protein-lipid inter-
actions are also likely to be affected by this modification.
Proper signaling within cells relies on a dynamic reorgan-
ization upon stimuli of the signaling receptors within dif-
ferent domains of the membrane that are thought to
assemble and disassemble for the signaling to proceed
[48]. We show here by FRAP analysis that INA-UV treat-
ment considerably reduces the mobile fraction of proteins
within plasma membranes. Whether this is due to a par-
tial aggregation of membrane proteins and/or a reorgani-
zation of domains to accommodate the enhanced
hydrophobicity needs to be further studied. The enhanced
basal activation of Akt following INA and light treatment
might also be a result of receptor immobilization/redistri-
bution. Furthermore, the ability of IGF1 to stimulate the
tyrosine kinase IGF1R receptor is considerably amplified
by INA treatment. IGF1R has been shown to relocalize in
membrane "raft" microdomains in MCF7 cells upon stim-
ulation with IGF1 [49] and activation of Akt also appears
to rely on its membrane redistribution [50] in membrane
"raft" microdomains [51]. Nevertheless Akt activation
induced by INA treatment does not prevent the cells to
undergo apoptosis suggesting the mechanism of cell
death induced by INA is independent of Akt signaling
pathway.
In this report we show the potency of INA as a novel and
efficient photoactivable chemotherapeutic agent. The
activity of this treatment is strictly dependent on activa-
tion by UV light and is mediated by the covalent reaction
of INA with membrane embedded domains of proteins.
Unlike conventional photodynamic sensitizer that are
dependent on reactive oxygen species for activity, reaction
of INA with membrane proteins has been shown to be
increased under hypoxic conditions [52]. Such hypoxic
conditions are common in tumors micro environment
and present a major challenge for other photosensitizers.
Furthermore, while INA can be directly activated by UV,
an equivalent activation can be obtained through energy
transfer processes called photosensitization using a vari-
ety of chromophores as photosensitizers [6]. The result
presented here show that INA is a very potent light activat-
able therapeutic agent whose targets and mechanism of
action are very different from existing PDT agents. Those
INA-UV treatment affects the translational diffusion of proteins in the cell membrane Figure 9
INA-UV treatment affects the translational diffusion of proteins in the cell membrane. Fluorescence recovery 
after photobleaching (FRAP) of CCR5-GFP expressed in Hela cells treated or not with 20 μM INA-UV. A. Fluorescence signal 
recovery as a function of time after photobleaching. B. Computed mobile fraction of CCR5-GFP in control cells and cells 
treated with 20 μM INA-UV. Data are mean ± S.D of seven measurements.
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properties of INA make it a unique candidate for use in
photoactivated cancer chemotherapy.
Conclusion
While INA by itself is innocuous to cells, INA-UV treat-
ment profoundly affects the physiology of various cancer
cell lines by inducing apoptosis. The covalent binding of
INA to transmembrane domains of proteins alters the sig-
naling capabilities of various cellular receptors in a com-
plex fashion. While G protein-coupled receptors are
completely inactivated, the IGF1 receptor remains sensi-
tive to IGF1 stimulation. The translational diffusion of
proteins is also profoundly affected by INA-UV treatment.
Interestingly, INA is not a substrate for the major multi
drug resistance proteins Pgp and MRP1. Furthermore, we
show that INA-UV can prevent the efflux capability of
MRP1. Overall, the photoactivation of INA in cells results
in a dose dependent apoptosis that can be exploited in
anti-cancer treatment.
Methods
Cells and reagents
The Phospho-Akt (Ser473) and Poly (ADP-ribose)
polymerase (PARP, clone 46D11) antibodies were
obtained from Cell Signaling (Danvers, MA). The breast
adenocarcinoma cell line MCF7 (obtained from the NCI
tumor repository) and the T lymphoblastoid cell line
SupT1 were propagated in RPMI (Invitrogen, Carlsbad,
CA) supplemented with 10% Fetal Bovine Serum (FBS)
(Invitrogen, Carlsbad, CA). The cervical cancer cell line
HeLa was propagated in Dulbecco's modified Eagle
medium (DMEM) (Lonza, Allendale, NJ) supplemented
with 5% FBS. The human glioma cell line U251 was a kind
gift of Dr Jacek Capala and was propagated in DMEM sup-
plemented with 10% FBS. The human ovarian carcinoma
cell line SKOV-3 and the human breast carcinoma cell line
SKBR-3 were a kind gift of Dr Jacek Capala and were prop-
agated in McCOY's 5A (ATCC, Manassas, VA) supple-
mented with 10% FBS. HEK 293 (293) is an epithelial cell
line from embryonic human kidney. 293/MRP1 was a
kind gift of Dr Suresh Ambudkar. It is a 293 clone that sta-
bly expresses multidrug resistant protein (MRP1) and is
propagated in DMEM supplemented with 10% FBS and
etoposide (5 μM). KB3-1 is a human epidermoid carci-
noma and KBV1 is a KB3-1 variant that overexpresses P
glycoprotein (Pgp) [53]. All propagation media were sup-
plemented with the antibiotics penicillin-streptomycin
(Invitrogen, Carlsbad, CA). Fura 2 and 4-bromo A-23187
were obtained from Invitrogen (Carlsbad, CA). RadioIm-
munoPrecipitation Assay (RIPA) buffer was obtained
from Upstate (Lake Placid, NY). All other reagents were
obtained from Sigma (Saint Louis, MO).
Irradiation procedure
INA was added to the cells from a 100× stock solution in
DMSO so that the final concentration desired was always
achieved with a 1% final DMSO concentration for all sam-
ples. The cells were irradiated with UV light using a 100-
W ozone-free mercury arc lamp placed in a lamp house
with a collector lens (Olympus) as the light source. Sam-
ples were irradiated through a 310-nm cutoff filter placed
in front of the lens (to allow transmission of the 313-,
334-, and 365-nm mercury emission bands) and through
a water filter (to prevent sample heating) at a distance of
5 cm from the light source. At that point, the light dose
was 10 mW/cm2 s. Irradiation times were 2 minutes.
MRP1 calcein flux measurement
293 cells or 293/MRP1 cells were irradiated with UV in the
presence of INA and incubated in medium for 30 minutes
at 37°C. In some cases, in order to prevent MRP1 func-
tion, the cells were then pretreated with 40 μM verapamil
for 30 minutes prior to calcein loading. The cells were
then labeled by incubation with 0.25 mM calcein AM for
30 minutes at 37°C. Cells were then washed twice with
PBS and the retained intracellular calcein was further
determined by fluorescence-activated cell sorting (FACS)
analysis on a FACScalibur flow cytometer (BD Bio-
science). At least 10,000 events were collected and ana-
lyzed using Cell quest software.
IGF1 mediated signal transduction
Signaling was measured by following the insulin-like
growth factor 1 (IGF1) dependent phosphorylation of Akt
protein [31]. MCF7 cells were plated in a 12 well plate in
RPMI. The medium was replaced with serum free RPMI
for overnight incubation. INA was added from 100× stock
solution in DMSO for each sample and the samples were
irradiated with a UV lamp as described above. IGF1 (R&D
systems, Minneapolis, MN) was then added to the
medium at a final concentration of 40 ng/ml and the sam-
ples were incubated for 10 minutes at 37°C. The cells were
then scraped on ice in PBS. The cells were lysed in RIPA
buffer supplemented with 2 mM sodium orthovanadate.
Proteins from the lysate were separated by electrophoresis
and subjected to Western blot analysis for the detection of
phosphorylated Akt.
Western blot analysis
Upon blotting, the membranes were incubated for 1 h in
Odyssey blocking buffer (LICOR, Lincoln, NE). The blots
were then incubated with the appropriate primary anti-
body for 2 h at room temperature in Odyssey blocking
buffer containing 0.2% Tween-20. The following dilu-
tions were used: 1/1000 for phospho-Akt, 1/4000 for
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
and 1/500 for PARP. Upon four washes of 10 min each
with 0.1% Tween-20 in PBS (PBST), the membranes were
incubated one hour with anti rabbit 800 and anti mouse
700 (LI-COR, Lincoln, NE) at a dilution of 1/5000 in
Odyssey blocking buffer with 0.2% Tween-20, and
washed four times for 10 min with PBST. Immunoreactiv-BMC Cell Biology 2009, 10:21 http://www.biomedcentral.com/1471-2121/10/21
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ity was detected by using an Odyssey infrared imaging sys-
tem (LI-COR, Lincoln, NE).
CXCR4 chemokine induced signaling
SupT1 cells were treated with 15 μM INA and labeled with
5 μM of Fura 2 for 30 minutes at room temperature. Cal-
cium flux was monitored in a FluoroMax-3 fluorimeter
from Horiba Jobin-Yvon (Edison, NJ, USA). The cells were
resuspended at 106/ml and the fluorescence emission was
recorded at 510 nm using simultaneous excitation at 340
and 380 nm. The calcium flux was triggered by the addi-
tion of the chemokine SDF1α (PeproTech, Rocky Hill, NJ)
at a final concentration of 35 ng/ml. Complete equilibra-
tion of the intracellular and extracellular calcium concen-
tration was achieved by the addition of the ionophore 4-
bromo A-23187 at a final concentration of 5 μM.
Apoptosis
Apoptosis was detected in cells 24 h post treatment using
various assays. Mitochondrial depolarization was
detected by staining with 10 nM 3,3'-dihexyloxacarbocya-
nine iodide (DiOC6) for 30 min at 37°C followed by flow
cytometry. Annexin V-FITC was used to detect PS exposure
on cells using ApoAlert kit (BD bioscience). DNA frag-
mentation was detected by terminal uridine deoxynucle-
otidyl transferase dUTP nick end labeling (TUNEL) using
In situ cell death detection kit (Roche). For PARP cleavage
analysis, SupT1 cells were treated with various amounts of
INA or doxorubicin. 24 hours upon treatment, the cells
were lysed with RIPA buffer for electrophoresis and West-
ern detection. CaspACE™ FITC-VAD-FMK (Promega) was
used following manufacturers instruction to detect cas-
pase activation by FACS analysis 24 h post treatment.
FRAP measurement and analysis
Fluorescence recovery after photobleaching (FRAP) was
performed as previously described [54] using a Zeiss LSM
510 (Carl Zeiss, Jena, Germany) confocal laser scanning
microscope. HeLa cells were plated on 35 mm glass bot-
tom dishes (MatTek, Ashland, MA) and transfected with
CCR5-GFP (a kind gift from Dr Santos-Manes [55]) 24
hours prior to confocal analysis as described previously
[54]. INA-UV treatment was performed as described
above. The cells were then submitted to FRAP while kept
at physiological conditions of 37°C and 5% CO2 in a
stage incubation system (Incubator S; PeCon GmbH,
Erbach, Germany). A 488 nm Ar+ laser line was used for
excitation and emission light was collected with a 500–
550 bandpass filter. A 40×/1.3 NA oil immersion objec-
tive lens was used with a zoom factor of 4. The detector
pinhole was opened slightly to acquire an optical section
of 2 μm thickness. This allowed more light to be collected
for better quantification. Three pre-bleach images were
acquired to determine the rate of non-purposeful photob-
leaching. Photobleaching was performed by increasing
the transmission of the laser to 100% for 20–50 iterations
to optimize the extent of bleaching. Following photob-
leaching 8–10 images were acquired at one second inter-
vals and then the acquisition rate was changed to ten
second intervals to follow the recovery to completion. A
total of 20–40 images were acquired. FRAP analysis was
performed using the MIPAV (CIT/NIH, Bethesda, MD)
software package using a 1D diffusion FRAP model to
retrieve the mobile fraction [56]. Data were automatically
corrected with background subtraction, as well as normal-
ization for the non-purposeful photobleaching rate calcu-
lated from the whole cell membrane.
MTS assay
The cells were plated a day before in a 96 wells plate at a
density of 2 104/well. The cells were then subjected to UV
irradiation in the presence of INA. A day after the treat-
ment, the cells were submitted to a 3-(4,5-dimethylthia-
zol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium, inner salt (MTS) assay
(CellTiter 96® AQueous One, Promega) as per the manufac-
turer's instructions. For IC50 calculation, seven independ-
ent measurements were performed and analyzed together.
IC50 values were computed by fitting a four-parameter
nonlinear regression model with R  statistical software
[57]. The standard error (SE) represents the 95% confi-
dence interval.
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